TrialThe Journal of infectious diseases2014

A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.

John J Treanor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.